January 21, 2020
Tag: Cancer Outcomes
January 16, 2020
Reuters Health: ‘List price’ for healthcare treatments in the U.S. may be misleading
January 16, 2020
Medscape: Even With Hospital Price Lists, ‘Shopping Around’ Still Difficult
January 16, 2020
Comparing cancer costs is challenging, despite new price transparency rules
Comparison shopping for airfare, a TV, or a car can be straightforward online. The same cannot be said for checking what hospitals charge for a standard radiation treatment for prostate cancer, according to a report published in JAMA Oncology. Trevor Royce, MD, MPH, MS, of the University of North Carolina Lineberger Comprehensive Cancer Center, is …
January 9, 2020
Pancreatic cancer patient beats the odds to thrive after diagnosis
The care team at UNC Lineberger helped Mary Gillam beat the odds and become a pancreatic cancer survivor. “I truly could not have gotten through this without Chapel Hill’s support,” she said. “The whole team has been outstanding.”
December 6, 2019
Cancer Therapy Advisor: When Patient-Reported Outcomes Could Pose Risks
November 19, 2019
Wood coauthors column on the value of collecting, assessing patient information outside the clinic via sensors
UNC Lineberger’s William Wood, MD, MPH, associate professor of medicine at the UNC School of Medicine, co-authored an opinion column published in STAT, an online medical and life sciences news site. The column describes the value of collecting patient information outside of the clinic. That data is captured by a sensor used outside of the clinic …
November 14, 2019
OncLive: Association of Community Cancer Centers Honors Ethan Basch, MD, MSc, With Clinical Research Award
November 4, 2019
Washington Post: For some cancer patients, monitoring symptoms can extend their lives
September 17, 2019
Hyundai Hope On Wheels awards Smitherman $200,000 grant to support cancer outcomes research in children, adolescents and young adults
Andrew Smitherman, MD, MSc, was awarded a two-year, $200,000 Hyundai Young Investigator Grant to investigate approaches to identify pediatric, adolescent and young adult cancer patients most at risk for late stage treatment side-effects.